FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, will highlight its ongoing...
Hence then, the article about quidelortho showcases leadership in transfusion medicine at aabb 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025 )
Also on site :
- GEEKOM revient au CES 2026 avec ses nouveaux ordinateurs portables haut de gamme et une génération inédite de Mini PC
- China’s LNG Imports Rebound Late in the Year After a Prolonged Slump
- JinkoSolar Announces Results of 2025 Annual General Meeting